Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study - The Lancet
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents | NEJM
Updated Toolkit: Children and COVID-19 Vaccination - Public Health Communication Collaborative
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
Your questions about coronavirus vaccines, answered - Washington Post
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine | Nature Medicine
Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England | Nature Communications
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021 | MMWR
Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection | NEJM
COVID-19 Vaccines Advice
Lessons Learned from Post–COVID-19 Vaccination PET/CT Studies | Journal of Nuclear Medicine
Post vaccination infection rare but possibly contagious; study refutes another anti-vax pregnancy claim | Reuters
Chart: 28 Days Later: The Pfizer/BioNTech Vaccination Process | Statista
Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study - The Lancet
Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 - The Lancet
